Modification of Tumor Suppressor Gene Expression and Induction of Apoptosis in Non-Small Cell Lung Cancer (NSCLC) with an Adenovirus Vector Expressing Wildtype p53 and Cisplatin. University of Texas M.D. Anderson Cancer Center, Houston, Texas
- 20 May 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (8) , 1013-1030
- https://doi.org/10.1089/hum.1996.7.8-1013
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- p53 Mutations in Human CancersScience, 1991
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- Genetic Mechanisms of Tumor Suppression by the Human p53 GeneScience, 1990
- p53: oncogene or anti-oncogene?Genes & Development, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5Virology, 1988
- Projections of Lung Cancer Mortality in the United States: 1985-20251JNCI Journal of the National Cancer Institute, 1988
- Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lungPublished by Elsevier ,1980